Oved Amitay

Nessuna posizione attualmente

58 anni

Health Technology

Consumer Services

Commercial Services

Profilo

Oved Amitay formerly worked at The Solve ME, as President, Chief Executive Officer & Director from 2020 to 2023, CeNeS Pharmaceuticals, Inc., as Staff Pharmacologist, Genzyme Corp., as Vice President-Strategic Development from 1998 to 2011, Alnylam Pharmaceuticals, Inc., as Vice President & Head-Commercial from 2012 to 2016, Peptor Ltd, as Staff Pharmacologist, Arrett Neuroscience, Inc., as President & Chief Operating Officer from 2016 to 2018, and Centogene NV, as Chief Business Officer from 2018 to 2020.
Mr. Amitay received his graduate degree from Northeastern University and undergraduate degree from The Hebrew University of Jerusalem.

Precedenti posizioni note di Oved Amitay

Società	Posizione	Fine
The Solve ME/CFS Initiative The Solve ME/CFS Initiative Miscellaneous Commercial ServicesCommercial Services The Solve ME/CFS Initiative is a non-profit organization that focuses on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), long COVID, and other post-infection diseases. The non-profit company is based in Glendale, CA. The organization provides answers and links to information for those living with and managing ME/CFS or long COVID. ME/CFS is a chronic, complex, neuroimmune disease that limits the health and productivity of patients and is often triggered by an infection. The organization's advocacy cafe chat series features community members sharing their stories to advocate for change. The Solve ME Research Advisory Council includes professionals from many fields that touch on ME/CFS. The company was founded in 1987. Oved Amitay has been the CEO of the company since 2020.	Amministratore Delegato	16/10/2023
CENTOGENE N.V.	Corporate Officer/Principal	31/05/2020
Arrett Neuroscience, Inc.	Presidente	01/01/2018
ALNYLAM PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/06/2016
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/01/2011

Vedi nel dettaglio l'esperienza di Oved Amitay

Formazione di Oved Amitay

Northeastern University	Graduate Degree
The Hebrew University of Jerusalem	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Oved Amitay

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
ALNYLAM PHARMACEUTICALS, INC.	Health Technology
CENTOGENE N.V.	Commercial Services

Aziende private	5
CeNeS Pharmaceuticals, Inc. CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals, Inc. discovers and develops proprietary pharmaceuticals to prevent and treat disorders and injuries of the nervous system. The company is headquartered in Cambridge, MA.	Health Technology
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Health Technology
Peptor Ltd	Health Technology
The Solve ME/CFS Initiative The Solve ME/CFS Initiative Miscellaneous Commercial ServicesCommercial Services The Solve ME/CFS Initiative is a non-profit organization that focuses on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), long COVID, and other post-infection diseases. The non-profit company is based in Glendale, CA. The organization provides answers and links to information for those living with and managing ME/CFS or long COVID. ME/CFS is a chronic, complex, neuroimmune disease that limits the health and productivity of patients and is often triggered by an infection. The organization's advocacy cafe chat series features community members sharing their stories to advocate for change. The Solve ME Research Advisory Council includes professionals from many fields that touch on ME/CFS. The company was founded in 1987. Oved Amitay has been the CEO of the company since 2020.	Commercial Services
Arrett Neuroscience, Inc.

Vedi le connessioni aziendali